--To the press -
FRONTEO Holds "AI Innovation Forum 2022"
The life science AI session has the largest number of participants, and the most attended lecture is "AI and mental illness"
FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Growth)
FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) held the 2022th private conference "FRONTEO AI Innovation Forum" on July 7, 12. Under the theme of "Realistic information society fairness created by innovative AI that can be realized only by natural language AI," AI research results that are indispensable for social implementation by instructors with diverse backgrounds and specialized knowledge And introduced the actual use.
At this conference, a total of 4 lectures were given on the four areas of Legal Tech AI, Business Intelligence, Life Science AI, and Economic Security.There were more applications for participation than last year's results, and more than 13 people, mainly from companies, medical institutions, government offices, etc.Among them, the largest number of participants were in the life science AI field, and the largest number was 1,600% in the lectures on the theme of "AI and mental illness".
In the questionnaire conducted after the event, 98.7% of the respondents answered that they were "satisfied" with the conference, and 96.1% answered that they were "interesting".In addition, 85.7% of the respondents answered that it was "easy to understand", indicating that it was an opportunity to provide useful information for the social implementation of innovative AI.
There are a wide variety of business areas that "want to utilize AI in-house", and it was found that the specialized areas required for social implementation of AI are extremely diverse. In order to meet these needs, FRONTEO will focus on providing AI performance and innovation, as well as the ability to apply it to specialized business and services up to implementation.
At the opening talk, FRONTEO President and CEO Masahiro Morimoto talked about the conditions necessary for AI to support expert judgment and the use of innovative technology, and the conference started.
In the keynote speech, Akira Amari, a member of the Liberal Democratic Party, will be on stage, and in order to bring about innovation, the "issue" is "value", and the labor cost for that purpose should be regarded as an investment rather than a cost. He talked about sex and emphasized the importance of human resources education that supports it.Professor Yukio Osawa of the University of Tokyo Graduate School of Engineering took the stage in the closing keynote, and discussed the necessity of human intervention for data utilization, detection and prediction of changes, along with examples.
Member of the House of Representatives Amari giving a keynote speech
Some of the lectures at this conference will be released on our website as archive videos at a later date (https://ai-forum.fronteo.com/). FRONTEO will continue to strive to provide services that contribute to improving the value of companies and institutions and solving problems.
[AI Innovation Forum 2022 Lecture List]
・ Opening talk
Masahiro Morimoto, President and CEO of FRONTEO Inc.
・ Keynote
"Who is the flag bearer of the new Industrial Revolution?"
Member of the House of Representatives Akira Amari, Liberal Democratic Party
・ Legal Tech AI Session
"Utilization of technology in international proceedings / arbitration cases and future prospects"
DLA Piper Tokyo Partnership Partner Tony Andriotis
Anderson Mori & Tomotsune Law Office Co-head of International Arbitration David MacArthur
・ Life Science AI Session
"Quantify mental illness with AI"
Keio University School of Medicine Hills Future Preventive Medicine / Wellness Joint Research Course Specially Appointed Professor Yashiro Kishimoto
"Predicting the risk of a patient's fall with AI"
Mr. Katsumi Hosokawa, Director of Nursing Department, HITO Hospital, Social Medical Corporation Ishikawa Memorial Association
"The future drawn by digital health-from the standpoint of a telecommunications carrier-"
Mr. Nobukazu Masaki, Manager, Business Innovation Headquarters, Nippon Telegraph and Telephone East Corporation
"FRONTEO's AI drug discovery that accelerates innovation"
FRONTEO Inc. Executive Officer / Director, Neuro-Language Science Institute AI Solution CTO Hiroyoshi Toyoshiba
"Accelerating and refining drug discovery and cell medicine research by co-variable network analysis method and expectations for AI technology"
Mr. Masayuki Murata, Director / Specially Appointed Professor, Multimodal Cell Analysis Joint Research Center, Tokyo Institute of Technology
・ Business intelligence session
"Advancement of VOC utilization-Building a foundation utilizing AI-"
Mr. Satoru Gushiken, General Manager, VOC Analysis Office, CX Promotion Department, Japan Post Insurance Co., Ltd.
"Aiming to realize innovation beyond DX"
Yamato Holdings Co., Ltd. and Yamato Transport Co., Ltd. Senior Managing Executive Officer Shinji Makiura
"Digitalization of" New Hiyari Hat Report "and Safety and Health Management DX"
Former General Manager of Technical Management Department, Construction Industry Occupational Accident Prevention Association Kenji Motoyama
・ Economic security session
"Diversifying Risks: Why Economic Security Is Needed Now"
Kazuto Suzuki, Professor, Graduate School of Public Policy, The University of Tokyo
・ Closing keynote
"Data Coupling Innovation Literacy-Creating a place for co-creation that depicts AI and the future-"
Yukio Osawa, Professor, Department of Systems Innovation, Graduate School of Engineering, The University of Tokyo
■ About FRONTEO URL: https://www.fronteo.com/
FRONTEO uses an in-house developed AI engine "KIBIT" specializing in natural language processing, "Concept Encoder (trademark: conceptencoder, reading: concept encoder)", and "Looca Cross (reading: Luca Cross)" to create a huge amount of text. It is a data analysis company that extracts meaningful and important information from data and supports the business of the company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support corporate international litigation. Has been deployed.Based on the AI technology cultivated in this business, we will expand the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge", We contribute to solving various corporate issues such as drug discovery support, dementia diagnosis support, finance, personnel, and sales support. Listed on TSE Mothers (currently TSE Growth) on June 2014, 2007. Obtained a first-class medical device manufacturing and sales business license in January 6 (permit number: 26B2021X1), and notified the managed medical device sales business in September of the same year (notification number: 13 Minato Misei Equipment No. 1).The capital is 10350 thousand yen (as of March 9, 3).
* FRONTEO, KIBIT, conceptencoder, and Looca Cross are registered trademarks of FRONTEO in Japan.